Blue Square Asset Management’s AstraZeneca AZN Stock Holding History

Blue Square Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,285	Closed	-$873K	–	82
2021 Q2	$873K	Sell	7,285 -614	-8%	-$67.4K	0.54%	53
2021 Q1	$785K	Buy	7,899 +403	+5%	+$40.5K	0.5%	56
2020 Q4	$749K	Buy	7,496 +1,746	+30%	+$185K	0.5%	60
2020 Q3	$630K	Buy	5,750 +2,852	+98%	+$317K	0.44%	51
2020 Q2	$306K	Sell	2,898 -3,641	-56%	-$376K	0.21%	50
2020 Q1	$584K	Sell	6,539 -1,777	-21%	-$167K	0.54%	41
2019 Q4	$829K	Buy	8,316 +3,867	+87%	+$364K	0.65%	39
2019 Q3	$397K	Buy	+4,449	New	+$386K	0.31%	53

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Blue Square Asset Management's AZN Position: Q3 2021 in Review

Blue Square Asset Management sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 7,285 shares — an estimated $873K sold.

Blue Square Asset Management first reported a position in AZN in Q3 2019 and held it in 8 quarters. The position peaked at $873K in Q2 2021. 906 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

Blue Square Asset Management reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
Blue Square Asset Management sold 7,285 AstraZeneca shares in Q3 2021, an estimated $873K.
Blue Square Asset Management first reported a position in AstraZeneca in Q3 2019 and held it in 8 quarters.
Blue Square Asset Management's AstraZeneca position peaked at $873K in Q2 2021.
906 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Blue Square Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.